ENTPD1

ENTPD1
Identifiers
Aliases	ENTPD1 , ATPDase, CD39, NTPDase-1, SPG64, ectonucleoside triphosphate diphosphohydrolase 1
External IDs	OMIM: 601752; MGI: 102805; HomoloGene: 20423; GeneCards: ENTPD1; OMA:ENTPD1 - orthologs
Gene location (Human) Chr. Chromosome 10 (human) [1] Band 10q24.1 Start 95,711,779 bp [1] End 95,877,266 bp [1]
Gene location (Mouse) Chr. Chromosome 19 (mouse) [2] Band 19 C3|19 34.25 cM Start 40,600,810 bp [2] End 40,730,046 bp [2]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in saphenous vein monocyte popliteal artery tibial arteries tendon of biceps brachii gallbladder right coronary artery urethra blood appendix Top expressed in ascending aorta aortic valve granulocyte spermatocyte spermatid atrioventricular valve lens stroma of bone marrow conjunctival fornix carotid body More reference expression data BioGPS More reference expression data
Gene ontology Molecular function nucleotide binding protein binding hydrolase activity ATP binding nucleoside-diphosphatase activity nucleoside-triphosphatase activity Cellular component integral component of membrane integral component of plasma membrane extracellular exosome membrane plasma membrane Biological process cell adhesion blood coagulation nucleobase-containing small molecule catabolic process Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 953 12495 Ensembl ENSG00000138185 ENSMUSG00000048120 UniProt P49961 P55772 RefSeq (mRNA) NM_001098175 NM_001164178 NM_001164179 NM_001164181 NM_001164182 NM_001164183 NM_001312654 NM_001776 NM_001320916 NM_009848 NM_001304721 RefSeq (protein) NP_001091645 NP_001157650 NP_001157651 NP_001157653 NP_001157654 NP_001157655 NP_001299583 NP_001307845 NP_001767 NP_001291650 NP_033978 Location (UCSC) Chr 10: 95.71 – 95.88 Mb Chr 19: 40.6 – 40.73 Mb PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Ectonucleoside triphosphate diphosphohydrolase-1 (gene: ENTPD1; protein: NTPDase1) also known as CD39 (Cluster of Differentiation 39), is a typical cell surface enzyme with a catalytic site on the extracellular face. ^{[5] [6] [7]}

Function

NTPDase1 is an ectonucleotidase that catalyse the hydrolysis of γ- and β-phosphate residues of triphospho- and diphosphonucleosides to the monophosphonucleoside derivative. ^{[8] [9]} NTPDase1 hydrolyzes P2 receptor ligands, namely ATP, ADP, UTP and UDP with similar efficacy. ^[10] NTPDase1 can therefore affect P2 receptor activation and functions. ^[11]

Clinical significance

ATP causes a pro-inflammatory environment, whereas degradation of ATP into adenosine by the CD39/CD73 pathway leads to an anti-inflammatory environment. ^[12] CD39 converts ATP (or ADP) to adenosine monophosphate (AMP), which is converted into adenosine by CD73. ^{[12] [13]} A substantial portion of the immune suppressive and anti-inflammatory activity of regulatory T cells (Tregs) is due to the adenosine produced by the CD39/CD73 pathway, insofar as Tregs express CD39 and CD73. ^{[12] [13]}

Adenosine produced by the CD39/CD73 pathway can protect against ischemia-reperfusion injury. ^[12] On the other hand, high expression and activity of CD39 and CD73 on cancer cells can prevent the immune system from inhibiting the progression of cancer. ^[12]

Biallelic pathogenic variant in ENTPD1 causes autosomal recessive spastic paraplegia 64 (SPG64). ^{[14] [15]} SPG64 is a complex hereditary spastic paraplegia characterized by childhood onset progressive spastic paraparesis, delayed developmental milestones, intellectual disability, dysarthria, and white matter abnormalities.

See also

• Cluster of differentiation

References

1. GRCh38: Ensembl release 89: ENSG00000138185 – Ensembl, May 2017
2. GRCm38: Ensembl release 89: ENSMUSG00000048120 – Ensembl, May 2017
3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. "Entrez Gene: ENTPD1 Ectonucleoside triphosphate diphosphohydrolase 1".
6. Sévigny J, Levesque FP, Grondin G, Beaudoin AR (Feb 1997). "Purification of the blood vessel ATP diphosphohydrolase, identification and localisation by immunological techniques". Biochimica et Biophysica Acta (BBA) - General Subjects. 1334 (1): 73–88. doi:10.1016/s0304-4165(96)00079-7. PMID   9042368.
7. Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (Dec 1996). "Identification and characterization of CD39/vascular ATP diphosphohydrolase". The Journal of Biological Chemistry. 271 (51): 33116–22. doi: 10.1074/jbc.271.51.33116 . PMID   8955160.
8. Robson SC, Sévigny J, Zimmermann H (Jun 2006). "The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance". Purinergic Signalling. 2 (2): 409–30. doi:10.1007/s11302-006-9003-5. PMC   2254478 . PMID   18404480.
9. Yegutkin GG (May 2008). "Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783 (5): 673–94. doi: 10.1016/j.bbamcr.2008.01.024 . PMID   18302942.
10. Kukulski F, Lévesque SA, Lavoie EG, Lecka J, Bigonnesse F, Knowles AF, Robson SC, Kirley TL, Sévigny J (Jun 2005). "Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8". Purinergic Signalling. 1 (2) 193: 193–204. doi:10.1007/s11302-005-6217-x. PMC   2096530 . PMID   18404504.
11. Kukulski F, Lévesque SA, Sévigny J (2011-01-01). "Impact of ectoenzymes on p2 and p1 receptor signaling". Pharmacology of Purine and Pyrimidine Receptors. Advances in Pharmacology. Vol. 61. pp. 263–99. doi:10.1016/B978-0-12-385526-8.00009-6. ISBN   978-0-12-385526-8. PMID   21586362.
12. Antonioli L, Pacher P, Vizi ES, Haskó G (2013). "CD39 and CD73 in immunity and inflammation". Trends in Molecular Medicine . 19 (6): 355–367. doi:10.1016/j.molmed.2013.03.005. PMC   3674206 . PMID   23601906.
13. Sepúlveda C, Palomo I, Fuentes E (2016). "Role of adenosine A2b receptor overexpression in tumor progression". Life Sciences . 166: 92–99. doi:10.1016/j.lfs.2016.10.008. PMID   27729268.
14. Novarino G, Fenstermaker AG, Zaki MS, et al. (Jan 2014). "Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders". Science. 343 (6170): 506–511. Bibcode:2014Sci...343..506N. doi:10.1126/science.1247363. PMC   4157572 . PMID   24482476.
15. Calame DG, Herman I, Maroofian R, et al. (Aug 2022). "Biallelic Variants in the Ectonucleotidase ENTPD1 Cause a Complex Neurodevelopmental Disorder with Intellectual Disability, Distinct White Matter Abnormalities, and Spastic Paraplegia". Ann Neurol. 92 (2): 304–321. doi:10.1002/ana.26381. hdl: 1887/3564840 . PMC   10054521 . PMID   35471564.

Further reading

• Maliszewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima T, Baker E, Sutherland GR, Poindexter K, Birks C (Oct 1994). "The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization". Journal of Immunology. 153 (8): 3574–83. doi:10.4049/jimmunol.153.8.3574. PMID   7930580. S2CID   34664153.
• Christoforidis S, Papamarcaki T, Galaris D, Kellner R, Tsolas O (Nov 1995). "Purification and properties of human placental ATP diphosphohydrolase". European Journal of Biochemistry. 234 (1): 66–74. doi: 10.1111/j.1432-1033.1995.066_c.x . PMID   8529670.
• Wang TF, Guidotti G (Apr 1996). "CD39 is an ecto-(Ca2+,Mg2+)-apyrase". The Journal of Biological Chemistry. 271 (17): 9898–901. doi: 10.1074/jbc.271.17.9898 . PMID   8626624.
• Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (Dec 1996). "Identification and characterization of CD39/vascular ATP diphosphohydrolase". The Journal of Biological Chemistry. 271 (51): 33116–22. doi: 10.1074/jbc.271.51.33116 . PMID   8955160.
• Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH (Jan 1997). "Loss of ATP diphosphohydrolase activity with endothelial cell activation". The Journal of Experimental Medicine. 185 (1): 153–63. doi:10.1084/jem.185.1.153. PMC   2196106 . PMID   8996251.
• Gray IC, Fallowfield J, Ford S, Nobile C, Volpi EV, Spurr NK (Jul 1997). "An integrated physical and genetic map spanning chromosome band 10q24". Genomics. 43 (1): 85–8. doi:10.1006/geno.1997.4809. PMID   9226376.
• Makita K, Shimoyama T, Sakurai Y, Yagi H, Matsumoto M, Narita N, Sakamoto Y, Saito S, Ikeda Y, Suzuki M, Titani K, Fujimura Y (Oct 1998). "Placental ecto-ATP diphosphohydrolase: its structural feature distinct from CD39, localization and inhibition on shear-induced platelet aggregation". International Journal of Hematology. 68 (3): 297–310. doi: 10.1016/S0925-5710(98)00080-2 . PMID   9846014.
• Matsumoto M, Sakurai Y, Kokubo T, Yagi H, Makita K, Matsui T, Titani K, Fujimura Y, Narita N (Jun 1999). "The cDNA cloning of human placental ecto-ATP diphosphohydrolases I and II". FEBS Letters. 453 (3): 335–40. doi: 10.1016/S0014-5793(99)00751-6 . PMID   10405171. S2CID   35474833.
• Kittel A, Kaczmarek E, Sevigny J, Lengyel K, Csizmadia E, Robson SC (Sep 1999). "CD39 as a caveolar-associated ectonucleotidase". Biochemical and Biophysical Research Communications. 262 (3): 596–9. Bibcode:1999BBRC..262..596K. doi:10.1006/bbrc.1999.1254. PMID   10471369.
• Koziak K, Kaczmarek E, Kittel A, Sévigny J, Blusztajn JK, Schulte Am Esch J, Imai M, Guckelberger O, Goepfert C, Qawi I, Robson SC (Jan 2000). "Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae". The Journal of Biological Chemistry. 275 (3): 2057–62. doi: 10.1074/jbc.275.3.2057 . PMID   10636909.
• Dias Neto E, Correa RG, Verjovski-Almeida S, Briones MR, Nagai MA, da Silva W, Zago MA, Bordin S, Costa FF, Goldman GH, Carvalho AF, Matsukuma A, Baia GS, Simpson DH, Brunstein A, de Oliveira PS, Bucher P, Jongeneel CV, O'Hare MJ, Soares F, Brentani RR, Reis LF, de Souza SJ, Simpson AJ (Mar 2000). "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags". Proceedings of the National Academy of Sciences of the United States of America. 97 (7): 3491–6. Bibcode:2000PNAS...97.3491D. doi: 10.1073/pnas.97.7.3491 . PMC   16267 . PMID   10737800.
• Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, Robson SC (Jul 2000). "CD39 modulates endothelial cell activation and apoptosis". Molecular Medicine. 6 (7): 591–603. doi:10.1007/BF03401797. PMC   1949966 . PMID   10997340.
• Kittel A, Garrido M, Varga G (Apr 2002). "Localization of NTPDase1/CD39 in normal and transformed human pancreas". The Journal of Histochemistry and Cytochemistry. 50 (4): 549–56. doi: 10.1177/002215540205000412 . PMID   11897808.
• Kaneider NC, Egger P, Dunzendorfer S, Noris P, Balduini CL, Gritti D, Ricevuti G, Wiedermann CJ (Jun 2002). "Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism". Arteriosclerosis, Thrombosis, and Vascular Biology. 22 (6): 894–900. doi: 10.1161/01.ATV.0000018305.95943.F7 . PMID   12067895.
• Drosopoulos JH (Oct 2002). "Roles of Asp54 and Asp213 in Ca2+ utilization by soluble human CD39/ecto-nucleotidase". Archives of Biochemistry and Biophysics. 406 (1): 85–95. doi:10.1016/S0003-9861(02)00414-9. PMID   12234494.
• Krötz F, Sohn HY, Keller M, Gloe T, Bolz SS, Becker BF, Pohl U (Dec 2002). "Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase". Arteriosclerosis, Thrombosis, and Vascular Biology. 22 (12): 2003–9. doi: 10.1161/01.ATV.0000043454.08172.51 . PMID   12482826.
• Rossatto ER, da Silva LB, Pereira GS, Bonan CD, Battastini AM, Ribeiro JP, Sarkis JJ (Feb 2003). "ATP diphosphohydrolase in human platelets from patients with coronary arteries heart disease". Platelets. 14 (1): 47–52. doi:10.1080/0953710021000062923. PMID   12623446. S2CID   24657425.
• Sørensen CE, Amstrup J, Rasmussen HN, Ankorina-Stark I, Novak I (Sep 2003). "Rat pancreas secretes particulate ecto-nucleotidase CD39". The Journal of Physiology. 551 (Pt 3): 881–92. doi:10.1113/jphysiol.2003.049411. PMC   2343304 . PMID   12832497.
• Sévigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, Imai M, Zimmermann H, Robson SC (Apr 2002). "Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation". Blood. 99 (8): 2801–9. doi: 10.1182/blood.v99.8.2801 . PMID   11929769.
• Novarino G, Fenstermaker AG, Zaki MS, et al. (Jan 2014). "Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders". Science. 343 (6170): 506–511. Bibcode:2014Sci...343..506N. doi:10.1126/science.1247363. PMC   4157572 . PMID   24482476.
• Calame DG, Herman I, Maroofian R, et al. (Aug 2022). "Biallelic Variants in the Ectonucleotidase ENTPD1 Cause a Complex Neurodevelopmental Disorder with Intellectual Disability, Distinct White Matter Abnormalities, and Spastic Paraplegia". Ann Neurol. 92 (2): 304–321. doi:10.1002/ana.26381. hdl: 1887/3564840 . PMC   10054521 . PMID   35471564.

External links

• ENTPD1+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)